These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39046787)

  • 1. Deep Learning-Based Identification of Tissue of Origin for Carcinomas of Unknown Primary Using MicroRNA Expression: Algorithm Development and Validation.
    Raghu A; Raghu A; Wise JF
    JMIR Bioinform Biotechnol; 2024 Jul; 5():e56538. PubMed ID: 39046787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New techniques to identify the tissue of origin for cancer of unknown primary in the era of precision medicine: progress and challenges.
    Ma W; Wu H; Chen Y; Xu H; Jiang J; Du B; Wan M; Ma X; Chen X; Lin L; Su X; Bao X; Shen Y; Xu N; Ruan J; Jiang H; Ding Y
    Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38343328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Transcriptome-Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic Cancer.
    Jeong Y; Chu J; Kang J; Baek S; Lee JH; Jung DS; Kim WW; Kim YR; Kang J; Do IG
    Curr Issues Mol Biol; 2024 Jul; 46(7):7291-7302. PubMed ID: 39057073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary.
    Hwang J; Lee Y; Yoo SK; Kim JI
    Neoplasia; 2024 Sep; 55():101021. PubMed ID: 38943996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate classification of metastatic brain tumors using a novel microRNA-based test.
    Mueller WC; Spector Y; Edmonston TB; St Cyr B; Jaeger D; Lass U; Aharonov R; Rosenwald S; Chajut A
    Oncologist; 2011; 16(2):165-74. PubMed ID: 21273512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary.
    Chen K; Zhang F; Yu X; Huang Z; Gong L; Xu Y; Li H; Yu S; Fan Y
    J Transl Med; 2022 Apr; 20(1):158. PubMed ID: 35382836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A second-generation microRNA-based assay for diagnosing tumor tissue origin.
    Meiri E; Mueller WC; Rosenwald S; Zepeniuk M; Klinke E; Edmonston TB; Werner M; Lass U; Barshack I; Feinmesser M; Huszar M; Fogt F; Ashkenazi K; Sanden M; Goren E; Dromi N; Zion O; Burnstein I; Chajut A; Spector Y; Aharonov R
    Oncologist; 2012; 17(6):801-12. PubMed ID: 22618571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site.
    Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T
    Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data.
    Liu X; Li L; Peng L; Wang B; Lang J; Lu Q; Zhang X; Sun Y; Tian G; Zhang H; Zhou L
    Front Genet; 2020; 11():674. PubMed ID: 32760423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
    Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
    JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
    Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
    Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary.
    Posner A; Sivakumaran T; Pattison A; Etemadmoghadam D; Thio N; Wood C; Fisher K; Webb S; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Fellowes A; Fox SB; Hicks RJ; Schofield P; Bowtell D; Prall OWJ; Tothill RW; Mileshkin L
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36720497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Tissue of Origin and Guided Therapeutic Applications in Cancers of Unknown Primary Using Deep Learning and RNA Sequencing (TransCUPtomics).
    Vibert J; Pierron G; Benoist C; Gruel N; Guillemot D; Vincent-Salomon A; Le Tourneau C; Livartowski A; Mariani O; Baulande S; Bidard FC; Delattre O; Waterfall JJ; Watson S
    J Mol Diagn; 2021 Oct; 23(10):1380-1392. PubMed ID: 34325056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
    Lorkowski SW; Dermawan JK; Rubin BP
    Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.
    Ferracin M; Pedriali M; Veronese A; Zagatti B; Gafà R; Magri E; Lunardi M; Munerato G; Querzoli G; Maestri I; Ulazzi L; Nenci I; Croce CM; Lanza G; Querzoli P; Negrini M
    J Pathol; 2011 Sep; 225(1):43-53. PubMed ID: 21630269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning for identifying resistance features of
    Liu W; Ying N; Mo Q; Li S; Shao M; Sun L; Zhu L
    J Med Microbiol; 2021 Nov; 70(11):. PubMed ID: 34812714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.